SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Stay informed with null’s coverage and analysis for Fortune.
Page 6 of 16
Health
How dangerous is Omicron really? COVID complacency could cause hospitalizations to rise
By
Sophie Mellor
Health
Booster shots are the best defense against Omicron. But a rush on extra jabs may make it harder to stop the rise of new variants
By
Grady McGregor
and
Sophie Mellor
Health
Omicron’s hospitalization rates are lower than previous COVID variants—at least in the hotspot that is South Africa
By
Sophie Mellor
Health
U.K. poised to overtake South Africa as world’s Omicron hotspot—with 200,000 infections a day
By
Sophie Mellor
Finance
GameStop unseats Tesla as the most searched-for stock of the year
By
Sophie Mellor
International
Omicron is making scientists redefine what it means to be ‘fully vaccinated’ against COVID
By
Sophie Mellor
International
Omicron cases soar in Britain as the world braces for new holiday COVID restrictions—and the backlash
By
Sophie Mellor
Finance
Bitcoin miners have returned to the record activity they had before China’s crypto crackdown—but they are still looking for a home
By
Sophie Mellor
Health
Scientists recommend COVID booster shots after 4 studies show vaccines may be less effective against the Omicron variant
By
Sophie Mellor
Health
GSK says its COVID antibody therapy works against Omicron. Here’s what other drugmakers say about their treatments
By
Sophie Mellor
Health
The WHO advises against convalescent plasma therapy to fight COVID-19, a therapy Donald Trump once hailed as a ‘beautiful ingredient’
By
Sophie Mellor
Finance
Bitcoin’s weekend carnage sends jitters through the crypto markets
By
Sophie Mellor
Health
Children, contagiousness, severity: What we know (and don’t know) about the Omicron COVID variant so far
By
Sophie Mellor
Health
Scientists push back against idea that Omicron is more dangerous than other COVID variants
By
Sophie Mellor
Retail
Inflation is coming for your closet—the cost of clothing to jump next year, new report shows
By
Sophie Mellor